Your browser doesn't support javascript.
loading
[Expression Levels of JARID1B, Hes1 and MMP-9 Genes in CML Patients Treated with Imatinib Mesylate].
He, Zhi-Kai; Xue, Seng; Zhang, Yong-Hong; Li, Lin; Xia, Yun-Jin; Wang, Xiang; Shi, Xin; Liu, Yu; Xu, Zheng; Li, Chen; Zhang, Jing-Xuan.
Afiliação
  • He ZK; Institute of Basic Medical Sciences, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.
  • Xue S; Institute of Basic Medical Sciences, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.
  • Zhang YH; Institute of Basic Medical Sciences, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.
  • Li L; Institute of Basic Medical Sciences, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.
  • Xia YJ; Department of Hematology, Taihe Hospital Affiliated to Hubei University of Medicine, Shiyan 442000, Hubei Province, China.
  • Wang X; Department of Hematology, Taihe Hospital Affiliated to Hubei University of Medicine, Shiyan 442000, Hubei Province, China.
  • Shi X; Department of Hematology, Taihe Hospital Affiliated to Hubei University of Medicine, Shiyan 442000, Hubei Province, China,Medical Research Institute, Wuhan University,Wuhan 430000, Hubei Province, China.
  • Liu Y; Department of Hematology, Taihe Hospital Affiliated to Hubei University of Medicine, Shiyan 442000, Hubei Province, China.
  • Xu Z; Key Laboratory of Targeted Intervention of Cardiovascular Diseases, Department of Pathophysiology, Nanjing Medical University, Nanjing 210000, Jiangsu Province, China.
  • Li C; Institute of Basic Medical Sciences, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China.
  • Zhang JX; Institute of Basic Medical Sciences, School of Basic Medical Sciences, Hubei University of Medicine, Shiyan 442000, Hubei Province, China,E-mail: zhangjx@hbmu.edu.cn.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 27(4): 1071-1076, 2019 Aug.
Article em Zh | MEDLINE | ID: mdl-31418359
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Limite: Humans Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib / Antineoplásicos Limite: Humans Idioma: Zh Revista: Zhongguo Shi Yan Xue Ye Xue Za Zhi Assunto da revista: HEMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China